PATENT CLAIM ANALYSIS

Application Number: 15954059
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are compositions and methods for the modulation of miR-214 for the treatment and/or prevention of fibrosis and fibroproliferative conditions.

Claim (Index 36):
The method of  claim 28 , wherein each internucleoside linkage of the modified oligonucleotide is a modified internucleoside linkage.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14872564', '15380629', '13811423', '14334872', '12919592']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8327062622749987
- 35 USC 102 Novelty (BERT): 0.5628925621252983
- Combined Prediction Score: 0.8057248922600286
- Mean Citation Score: 430.131018
- Max Citation Score: 450.4595
- Similarity Product: 370.3739764089286

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test